NCT05278780 (MA-ASAP) is a NA clinical trial of Screening for eligibility in Abortion Early, sponsored by Gynuity Health Projects.

Who is sponsoring NCT05278780?

NCT05278780 is sponsored by Gynuity Health Projects.

What drugs are being tested in NCT05278780?

Interventions in NCT05278780: Screening for eligibility.

What condition does NCT05278780 study?

NCT05278780 studies Abortion Early.

Is NCT05278780 still recruiting?

NCT05278780 is currently completed. Last updated 27 January 2025.

Last reviewed 2025-01-27 · How we verify

NCT05278780: MA-ASAP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Medication Abortion With Autonomous Self-Assessment Project

Completed NA Last updated 27 January 2025

What this trial tests

NA trial testing Screening for eligibility in Abortion Early in 200 participants. Completed in 15 April 2023.

Timeline

1 June 2022

Primary endpoint
1 March 2023

15 April 2023

Quick facts

Lead sponsor	Gynuity Health Projects
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	screening
Enrollment	200
Start date	1 June 2022
Primary completion	1 March 2023
Estimated completion	15 April 2023
Sites	2 locations across United States

Drugs / interventions tested

Screening for eligibility

Conditions studied

Abortion Early — all drugs for Abortion Early →

Sponsor

Gynuity Health Projects — full company profile →

Who can join

18 and older, female only, with Abortion Early. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the investigators propose to create and pilot-test an asynchronous medication abortion provision service.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Abortion Early

Currently open trials in the same condition.

NCT06787274 — Research on Equity in Abortion Care by TeleHealth · recruiting

Other Gynuity Health Projects trials

Trials by the same sponsor.

NCT06492889 — Assessing the Efficacy and Acceptability of Two Missed Period Pills Regimens · Phase 2, PHASE3 · not yet recruiting
NCT05781061 — MA-ASAP at Independent Abortion Clinics: A Demonstration Project · NA · completed
NCT05119439 — Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks · Phase 4 · terminated
NCT05459142 — Telemedicine Medical Abortion Service Using the "No-test" Protocol in Azerbaijan. · completed
NCT05207644 — Letrozole and Misoprostol for Termination of Pregnancy up to 63 Days' Gestation · Phase 2 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05278780 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gynuity Health Projects
Last refreshed: 27 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05278780.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing